Blue Biofuels Reports $422K Net Loss in Q3 2025, Revenue Stays at $0

Blue Biofuels, Inc. reported its financial results for the third quarter of 2025, revealing a continued lack of revenue generation, with total revenues remaining at $0 for both the three and nine months ended September 30, 2025, consistent with the same periods in 2024. The company incurred a net loss of $422,547 for the third quarter, compared to a net income of $1,866,081 in the prior year, primarily due to increased operating expenses. For the nine-month period, the net loss was $1,587,132, a significant decline from a net income of $370,386 in 2024. The total operating expenses for the nine months increased to $2,427,662 from $2,092,547, driven by higher general and administrative costs and research and development expenses.

The company's balance sheet as of September 30, 2025, showed total assets of $1,486,201, an increase from $1,389,587 at the end of 2024. Current assets rose to $106,645, up from $81,286, largely due to an increase in cash and cash equivalents, which reached $95,194 compared to $48,797 at the end of the previous year. However, total liabilities also increased to $4,543,537 from $4,235,490, reflecting a rise in deferred wages and directors' fees. The stockholders' deficit widened to $3,057,336 from $2,845,903, indicating ongoing financial challenges.

Strategically, Blue Biofuels has focused on advancing its patented Cellulose-to-Sugar (CTS) technology, which is designed to convert cellulosic materials into biofuels. The company has made progress in its pilot plant operations and has received a $1.15 million grant from the U.S. Department of Energy to support the commercialization of its CTS process. Additionally, Blue Biofuels formed a joint venture with Vertimass to develop a facility for converting ethanol into sustainable aviation fuel (SAF), aiming to produce 5-10 million gallons of SAF initially, with plans for expansion.

Operationally, the company has not reported any significant customer counts or product adoption rates, as it remains in the development phase. The employee headcount and engagement metrics were not disclosed in the filing. The company continues to face substantial doubt regarding its ability to continue as a going concern, as it has not generated significant revenue since its inception and has incurred cumulative losses of $58,842,893. Management has indicated that future success will depend on obtaining necessary financing and achieving profitable operations.

Looking ahead, Blue Biofuels anticipates needing additional capital to fund its operations and complete the development of its commercial facilities. The company plans to pursue project financing for its ethanol-to-SAF facility and aims to generate revenue through the commercialization of its CTS technology. However, there are no assurances that the company will be able to secure the necessary funding or achieve its operational goals, which could materially impact its financial position and viability.